Oramed to Present at the Upcoming Canaccord Genuity Annual Growth Conference July 11, 2022 Press Releases
Oramed Completes Patient Enrollment in Pivotal Phase 3 Oral Insulin Study ORA-D-013-1 May 3, 2022 Press Releases
Oramed’s Diabetes Market Survey Shows Strong Interest for ORMD-0801 Oral Insulin Candidate Among Physicians March 29, 2022 Press Releases
